Life sciences tools company Agilent Technologies (NYSE: A) will be reporting results this Wednesday after market close. Here’s what to expect.
Agilent beat analysts’ revenue expectations by 2.7% last quarter, reporting revenues of $1.67 billion, up 6% year on year. It was a mixed quarter for the company, with an impressive beat of analysts’ organic revenue estimates.
Is Agilent a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Agilent’s revenue to grow 5.6% year on year to $1.67 billion, a reversal from the 5.6% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.37 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Agilent has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.5% on average.
Looking at Agilent’s peers in the research tools & consumables segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Sotera Health Company delivered year-on-year revenue growth of 6.4%, beating analysts’ expectations by 6.8%, and Mettler-Toledo reported revenues up 3.9%, topping estimates by 2.9%. Sotera Health Company traded up 25.1% following the results while Mettler-Toledo was down 3%.
Read our full analysis of Sotera Health Company’s results here and Mettler-Toledo’s results here.
There has been positive sentiment among investors in the research tools & consumables segment, with share prices up 4.4% on average over the last month. Agilent’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $137.57 (compared to the current share price of $120.05).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
